Early diagnostic biomarkers of Lung cancer; a review study

Abstract

Lung cancer is the main cause of cancer-related death. Typically, lung cancer has been classified in two histologic types; small and non-small cell (NSC), with adenocarcinoma, squamous cell form and large cell type. The availability of predictive biomarkers for the treatment of NSC lung cancer (NSCLC) has been changed in recent decades, especially in the form of adenocarcinoma. Controlling for sensitizing mutations inside the epidermal growth factor receptor (EGFR) for patients with advanced adenocarcinomas is currently needed before the achievement of anti-EGFR inhibitors (such as erlotinib, gefitinib, afatinib or osimertinib). In a patient with no signs of tumor tissue, the EGFR mutational plasma and urine examination may be performed. ALK gene rearrangement research is required to predict crizotinib reaction. Treatment with ceritinib, alectinib or brigatinib also relies on ALK rearrangements. PD-L1 should be tested with an approved assay to model reactions in patients with advanced adenocarcinoma or squamous cell NSCLCs to the single pembrolizumab agent in their first-line therapy. As miRNAs are a vital biomarker (diagnostic biomarkers), miRNAs also could be used as a dynamic tumor predictor before and during therapy because of their function in carcinogenesis at all stages. Nevertheless, lncRNA sheds fresh insight into our tumor pathway perception. In biomedicine, lncRNA is intensely involved, which can be used for a wide variety of cancers as a clinical diagnostic and prediction predictor.

Authors and Affiliations

Mostafa Khafaei; Ali Miri; Ebrahim Kiani; Elham Danesh; Mehdi Naderi

Keywords

Related Articles

The moisture determination of bee pollen from Sivas Province in Anatolia and their antiproliferative activities in MCF-7 cell line

Pollen, one of the bee products, is an important nutrient for bees. Pollen is mainly used for feeding adult, old and larval bees to meet their needs for protein, vitamins and minerals. Since the protein content of pollen...

Investigation of the effect of pd1.1, pd1.5, and pd1.9 mutations on pd1 gene function with a system biology approach

Programmed cell death 1 (pd1) is an immune-inhibitory receptor that is expressesd in activated T cells. This gene may play a role in the inhibition of actual anti- microbial and anti-tumor immunity. In human, this gene i...

Description of the characteristics, epidemiology, diagnosis, and risk factors of presbycusis disorder

Presbycusis is one of the most important and common diseases associated with aging. This disease is a symmetrical, irreversible and progressive bilateral disease of the cochlea. Complications of presbycusis include perce...

The role of molecular factors in gestational hypertension and the pathogenesis of preeclampsia

Preeclampsia (PE) is classified as a systemic condition that generally develops with high blood pressure and protein excretion in pregnant women after 20 weeks. This condition is characterised by inadequate placental blo...

Association of glutathione S-transferase M1 null mutation with male infertility: A pooled data from Iranian studies

Male infertility is a complex disease in which environmental factors and genetic background are known to be the main causes of pathogenesis. The imbalance in production and elimination of free radicals due to oxidative s...

Download PDF file
  • EP ID EP714353
  • DOI 10.22034/CAJMPSI.2021.03.02
  • Views 96
  • Downloads 0

How To Cite

Mostafa Khafaei; Ali Miri; Ebrahim Kiani; Elham Danesh; Mehdi Naderi (2021). Early diagnostic biomarkers of Lung cancer; a review study. Central Asian Journal of Medical and Pharmaceutical Sciences Innovation, 1(3), -. https://www.europub.co.uk/articles/-A-714353